CAR T-Cells in Acute Lymphoblastic Leukemia: Current Status and Future Prospects
The currently available treatment for acute lymphoblastic leukemia (ALL) is mainly dependent on the combination of chemotherapy, steroids, and allogeneic stem cell transplantation. However, refractoriness and relapse (R/R) after initial complete remission may reach up to 20% in pediatrics. This perc...
Автори: | , |
---|---|
Формат: | Стаття |
Мова: | English |
Опубліковано: |
MDPI AG
2023-10-01
|
Серія: | Biomedicines |
Предмети: | |
Онлайн доступ: | https://www.mdpi.com/2227-9059/11/10/2693 |